124 related articles for article (PubMed ID: 30096371)
1. Effect of a C-end rule modification on antitumor activity of thymosin α1.
Wang F; Xu C; Peng R; Li B; Shen X; Zheng H; Lao X
Biochimie; 2018 Nov; 154():99-106. PubMed ID: 30096371
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
[TBL] [Abstract][Full Text] [Related]
3. Modified Thymosin Alpha 1 Distributes and Inhibits the Growth of Lung Cancer in Vivo.
Peng R; Xu C; Zheng H; Lao X
ACS Omega; 2020 May; 5(18):10374-10381. PubMed ID: 32426594
[TBL] [Abstract][Full Text] [Related]
4. A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.
Lao X; Li B; Liu M; Shen C; Yu T; Gao X; Zheng H
Apoptosis; 2015 Oct; 20(10):1307-20. PubMed ID: 26283169
[TBL] [Abstract][Full Text] [Related]
5. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
[TBL] [Abstract][Full Text] [Related]
6. A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1.
Lao X; Liu M; Chen J; Zheng H
PLoS One; 2013; 8(8):e72242. PubMed ID: 23977262
[TBL] [Abstract][Full Text] [Related]
7. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
[TBL] [Abstract][Full Text] [Related]
8. Thymosin α1 inserts N terminus into model membranes assuming a helical conformation.
Nepravishta R; Mandaliti W; Eliseo T; Sinibaldi Vallebona P; Pica F; Garaci E; Paci M
Expert Opin Biol Ther; 2015; 15 Suppl 1():S71-81. PubMed ID: 25642593
[TBL] [Abstract][Full Text] [Related]
9. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
[TBL] [Abstract][Full Text] [Related]
10. Proliferative and anti-proliferative effects of thymosin alpha1 on cells are associated with manipulation of cellular ROS levels.
Qin Y; Chen FD; Zhou L; Gong XG; Han QF
Chem Biol Interact; 2009 Aug; 180(3):383-8. PubMed ID: 19442654
[TBL] [Abstract][Full Text] [Related]
11. Historical review on thymosin α1 in oncology: preclinical and clinical experiences.
Garaci E; Pica F; Matteucci C; Gaziano R; D'Agostini C; Miele MT; Camerini R; Palamara AT; Favalli C; Mastino A; Serafino A; Sinibaldi Vallebona P
Expert Opin Biol Ther; 2015; 15 Suppl 1():S31-9. PubMed ID: 26096345
[TBL] [Abstract][Full Text] [Related]
12. Thymosin alpha1. SciClone Pharmaceuticals.
Billich A
Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
[TBL] [Abstract][Full Text] [Related]
13. Immunopharmacology of thymosin alpha1 and cytokine synergy.
Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW
Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
Li W; Song L; Wu S; Xue X; Zhang L; He L; Han W; Wang Q; Ling R; Zhang W; Yan Z; Zhang Y
Int J Biol Sci; 2011; 7(5):618-28. PubMed ID: 21647330
[TBL] [Abstract][Full Text] [Related]
15. Clonal growth inhibition as a bioassay for thymosin alpha1: inactivation of Talpha1 by trifluroacetic acid.
Bianco-Batlles D; Naylor CW; Moshier JA; Dosescu J; Naylor PH
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):157-60. PubMed ID: 11292250
[TBL] [Abstract][Full Text] [Related]
16. Thymosin alpha1 suppresses proliferation and induces apoptosis in human leukemia cell lines.
Fan YZ; Chang H; Yu Y; Liu J; Wang R
Peptides; 2006 Sep; 27(9):2165-73. PubMed ID: 16644063
[TBL] [Abstract][Full Text] [Related]
17. Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway.
Guo Y; Chang H; Li J; Xu XY; Shen L; Yu ZB; Liu WC
Apoptosis; 2015 Aug; 20(8):1109-21. PubMed ID: 26002438
[TBL] [Abstract][Full Text] [Related]
18. Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK.
Mandaliti W; Nepravishta R; Pica F; Vallebona PS; Garaci E; Paci M
Molecules; 2017 Oct; 22(11):. PubMed ID: 29077041
[TBL] [Abstract][Full Text] [Related]
19. Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.
Maio M; Mackiewicz A; Testori A; Trefzer U; Ferraresi V; Jassem J; Garbe C; Lesimple T; Guillot B; Gascon P; Gilde K; Camerini R; Cognetti F;
J Clin Oncol; 2010 Apr; 28(10):1780-7. PubMed ID: 20194853
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory function of orally administered thymosin alpha1.
Chen XM; Jiang HL; Zhou LF; Pan XP; Hu ZR; Liu RH; Chen XM; Chen Z
J Zhejiang Univ Sci B; 2005 Sep; 6(9):873-6. PubMed ID: 16130188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
